Colon Cancer Clinical Trial
— COLRABIOfficial title:
Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Colon Resections for Cancer Versus no Bowel Preparation
NCT number | NCT05546892 |
Other study ID # | COL-2 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | February 10, 2023 |
Est. completion date | September 2025 |
The purpose of the study is to determine if short-term outcomes of colon resections after full bowel preparation (mechanical bowel preparation plus oral antibiotics) are superior to colon resections with no bowel preparation.
Status | Recruiting |
Enrollment | 586 |
Est. completion date | September 2025 |
Est. primary completion date | September 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - histologically confirmed adenocarcinoma of the colon (caecum, ascending, transverse, descending, sigmoid) - clinical stage T1-4aN0-2M0-1 (distant metastases must be resectable) - indications for surgical colonic resection - ECOG status 0-2 - At least 18 years of age - Written informed consent Exclusion Criteria: - Medical or psychiatric conditions that compromise the patient's ability to give informed consent or comply with the study protocol - Pregnancy or breast feeding - Medical contraindications for surgical treatment - Any use of antibiotics 30 days prior to inclusion - Functioning stoma - Contraindications for use of MBP or OA drugs or their components - Indications for mandatory MBP (planned intraoperative colonoscopy etc) - Indications for obstructive resection - Acute bowel obstruction, bleeding or perforation - Other malignancies not in remission |
Country | Name | City | State |
---|---|---|---|
Russian Federation | N.N. Petrov National Medical Research Center of Oncology | Saint Petersburg |
Lead Sponsor | Collaborator |
---|---|
N.N. Petrov National Medical Research Center of Oncology |
Russian Federation,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Anastomotic leak rate | Rate of anastomotic leak in patients after colon resections | 30 days | |
Secondary | Surgical site infection (SSI) rate | Rate of Surgical site infection | 30 days | |
Secondary | Intraabdominal and or pelvic abscess rate | Rate of intraabdominal and or pelvic abscess | 30 days | |
Secondary | Overall morbidity | Rate of patients with any complications after surgery | 30 days | |
Secondary | Rate of intraoperative complications | Rate of patients with intraoperative complications | Duration of surgical procedure | |
Secondary | Surgery duration in minutes | Time of surgical procedure | Duration of surgical procedure | |
Secondary | Quality of bowel preparation assessed by surgeon | Assessment of bowel preparation quality by surgeon (qualitative scale) | Day of surgical procedure | |
Secondary | Bowel preparation compliance | Rate of patients in experimental arm undergoing complete bowel preparation according to protocol | Day of surgical procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT03457454 -
Reducing Rural Colon Cancer Disparities
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04088955 -
A Digimed Oncology PharmacoTherapy Registry
|
||
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Terminated |
NCT01347645 -
Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03390907 -
Hybrid APC Assisted EMR for Large Colon Polyps
|
N/A | |
Recruiting |
NCT03175224 -
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
|
Phase 2 | |
Completed |
NCT04079478 -
The AID Study: Artificial Intelligence for Colorectal Adenoma Detection
|
||
Active, not recruiting |
NCT04057274 -
Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth
|
N/A | |
Recruiting |
NCT03190941 -
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05147545 -
Impact of Exercise and Hyperlipidic Meal on Free Circulating DNA in Patients With Metastatic Colonic Cancer and Healthy Subjects
|
N/A | |
Recruiting |
NCT05026268 -
The Laparoscopic Right Colectomy With Intracoroporeal Anastomosis
|
N/A | |
Not yet recruiting |
NCT03277235 -
Effect of a Resilience Model-Based Care Plan in Newly Diagnosed Colorectal Cancer Patients
|
N/A | |
Active, not recruiting |
NCT02730702 -
Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure
|
||
Active, not recruiting |
NCT02959541 -
PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer
|
N/A | |
Completed |
NCT02810652 -
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
|
N/A | |
Recruiting |
NCT02577627 -
Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC
|
N/A | |
Terminated |
NCT02628535 -
Safety Study of MGD009 in B7-H3-expressing Tumors
|
Phase 1 | |
Recruiting |
NCT02526836 -
Complete Mesocolic Excision With Central Vessel Ligation Compared With Conventional Surgery for Colon Cancer
|
Phase 2/Phase 3 |